The Staff Research Associate engages in extensive in vitro and in vivo studies of next generation T cell therapies for solid tumors. These studies will include molecular biology (cloning), gene-editing and viral and non-viral transduction of T cells, cell culture, engineered T cell activity (CAR T, TCR T etc) assays (cytotoxicity, proliferation, cell phenotype assessment via flow), in vivo assessment of cell therapies in xenograft and syngeneic settings and general lab support to maintain critical reagents. In vivo work will include tail vein injections of engineered T cells and subcutaneous or intraperitoneal injections of tumor cells into NSG mice or immuncompetent mice (syngeneic mouse tumor models). For all st